Priority Date: 30.05.12 (US 201261689285P)

MATRIX METALLOPROTEINASE CLEAVABLE PROTEIN POLYMERS FOR CANCER GENE THERAPY

  • Application ID: EP13796535
  • Status: GRANT OF PATENT INTENDED

Applicant

Attorney

operating since 2017
4 offices
active in Legal Services

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING) is specialized in the combination A61 and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Sperling Fischer & Heyner, Zacco Denmark A/S, Lederer Keller Patentanwälte Partnerschaft mbB and 174 others are specialized in all of these IPC classes. For a similar patent, they might be a good choice.

Timeline

  • 30.05.2012 - Priority Date (US 201261689285P)
  • 05.12.2013 - Publication A2 (WO2013181471)
  • 22.04.2015 - Publication A2 (EP2861732)

IPC Classification